Researchers at Harry Perkins Institute of Medical Research, The University of Western Australia and Curtin University have made a fundamental discovery about the regulation of genes in mitochondria, providing new insights into potential drug targets for diseases that involve energy loss.
The research, published in Science Advances, was led by Perkins Mitochondrial Medicine and Biology laboratory head, Professor Aleksandra Filipovska, in collaboration with Curtin University’s Professor Oliver Rackham, Head of Synthetic Biology and Drug Discovery at the Perkins; and UWA’s School of Human Sciences Professor Livia Hool, and their PhD students Danielle Rudler and Laetitia Hughes.
Mitochondria – the biological energy ‘factories’ in cells – are unique because they are composed of proteins encoded by the chromosomes as well as the mitochondrial DNA inside these double membrane parts of the cell. The two genomes have to work cooperatively to assemble the machines that make energy.
Professor Filipovska said research into how energy production was crucial to the understanding of cell function and would provide a means to treat diseases caused by imbalance or loss of energy such as neurodegenerative and cardiovascular diseases.
“The regulation of genes inside mitochondria, which are the powerhouses of the cell, is essential because they produce the building blocks for the molecular machines that produce energy,” she said.
“We are at the beginning stages of understanding how proteins that are essential for energy production are made. Our recent discovery identifies the fine-tuning mechanisms that coordinate the synthesis and assembly of the energy producing machines in our cells.
“We identified a new factor that pauses protein synthesis to enable assembly of the energy producing machinery. This is a unique mechanism to regulate protein synthesis in mitochondria.”
Professor Filipovska said as well as providing a target for drug treatments of diseases involving energy loss such as cardiovascular diseases, the discovery was made possible by cutting-edge technologies to investigate changes in energy requirements in living systems.
“Defects in mitochondrial function cause many common diseases such as neurodegenerative, metabolic and heart diseases, cancer, diabetes and ageing,” she said.
“Therefore fundamental discoveries about how energy is produced empowers us to tailor treatments and develop new drugs.”
